medigraphic.com
Instituto Nacional de Salud Pública

2020, Número 5

<< Anterior Siguiente >>

salud publica mex 2020; 62 (5)


Brechas entre la oferta y la demanda del tratamiento de infarto agudo al miocardio en México

Pérez-Cuevas R, Contreras-Sánchez SE, Doubova SV, García-Saisó S, Sarabia-González O, Pacheco-Estrello P, Arias-Mendoza A

Idioma: Ingles.
Referencias bibliográficas: 39
Paginas: 540-549
Archivo PDF: 368.06 Kb.


RESUMEN

Objetivo. Analizar las tendencias de admisiones y mortalidad hospitalaria por infarto agudo al miocardio (IAM) y evaluar la competencia hospitalaria de la Secretaría de Salud (SS) para tratarlo. Material y métodos. Enfoque de métodos mixtos: Jointpoint análisis de tendencias de hospitalizaciones y mortalidad hospitalaria entre 2005 y 2017, y encuesta en hospitales de la SS. Resultados. Las hospitalizaciones por IAM están aumentando entre hombres y pacientes ›60 años. Las mujeres tienen mayor mortalidad. La encuesta incluyó 527 hospitales (2º nivel =471, 3er nivel =56). Los hospitales tienen competencias insuficientes para diagnosticar IAM (2º nivel 37%, 3er nivel 51%), realizar perfusión farmacológica (2º nivel 8.7%, 3er nivel 26.8%) y reperfusión mecánica (2º nivel 2.8%, 3er nivel 17.9%). Conclusiones. Existen disparidades en demanda, oferta y resultados en salud del IAM. Es aconsejable fortalecer las competencias, con perspectivas de género y edad, para diagnosticar y tratar IAM, y reducir su mortalidad efectivamente.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Institute for Health Metrics and Evaluation. GBD Compare Data Visualization. Seattle, WA: IHME, University of Washington, 2017 [cited April 26, 2018]. Available from: http://vizhub.healthdata.org/gbd-compare

  2. Stevens B, Verdian L, Pezzullo L, Tomlinson J, Nugent J. The Economic Burden of Myocardial Infarction in Latin America. Value Health 2016;19: A646 [cited April 26, 2018]. Available from: https://www.valueinhealthjournal. com/article/S1098-3015(16)33090-X/pdf

  3. Organisation for Economic Cooperation and Development. Health at a Glance 2017: OECD Indicators. Paris: OECD Publishing, 2017. https://doi. org/10.1787/health_glance-2017-en

  4. Loàisiga-Ruiz RJ. Evolución clínica del síndrome coronario agudo en pacientes ingresados en el hospital regional San Juan de Dios de Esteli en el periodo enero del 2014 a diciembre del 2014 [tesis de especialista en Medicina de Emergencias]. Managua: Universidad Nacional Autónoma de Nicaragua, 2016. [cited April 26, 2018]. Available from: http://repositorio. unan.edu.ni/1588/1/61948.pdf

  5. Pereda-Joh CM, Espinoza-Alva D. Mortalidad y complicaciones en el síndrome coronario agudo con elevación del segmento ST. Rev Card CM Ins Nac Card. 2015;3:7-11 [cited Jan 28, 2018]. Available from: http://www. cmincor.org/ojs/index.php/rccminc/issue/view/1

  6. Gagliard JA, Charask A, Perna E, D’imperio H, Bono J, Castillo-Costa Y, et al. National survey of ST-Segment Elevation Acute Myocardial Infarction in Argentina (ARGEN-IAM-ST). Rev Argent Cardiol. 2016;84(6):548-57. https://doi.org/10.7775/rac.es.v84.i6.9508

  7. Piegas LS, Avezum A, Guimarães HP, Muniz AJ, Reis HJ, Santos ES, et al. Acute coronary syndrome behavior: results of a Brazilian registry. Arq Bras Cardiol. 2013;100(6):502-10. https://doi.org/10.5935/abc.20130101

  8. Soto M, Buitrago AF, Gómez M, Celis E. Quality indicators in the care of patients with acute myocardial infarction. Rev Col Cardiol. 2014;21(5):301-7. https://doi.org/10.1016/j.rccar.2014.07.002

  9. Nguyen HL, Saczynski JS, Gore JM, Goldberg RJ. Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes. 2010;3(1):82-92. https://doi.org/10.1161/CIRCOUTCOMES.109.884361

  10. Bird MW, Woods AG, Warren NA. Factors influencing treatment delays for acute myocardial infarction. Crit Care Nurs Q. 2009;32(1):19-23. https://doi.org/10.1097/01.CNQ.0000343130.89200.57

  11. Albarqouni L, Smenes K, Meinertz T, Schunkert H, Fang X, Ronel J, Ladwing KH. Patients’ knowledge about symptoms and adequate behaviour during acute myocardial infarction and its impact on delay time: Findings from the multicentre MEDEA Study. Patient Educ Couns. 2016;99(11):1845-51. https://doi.org/10.1016/j.pec.2016.06.007

  12. Kereiakes DJ, Gibler WB, Martin LH, Pieper KS, Anderson LC. Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: a preliminary report from the Cincinnati Heart Project. Am Heart J. 1992;123(4):835-40. https://doi.org/10.1016/0002- 8703(92)90684-n

  13. Weaver WD. Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol. 1995;25(suppl):S3-9. https://doi.org/10.1016/0735-1097(95)00108-g

  14. Lambrew CT, Bowlby LJ, Rogers WJ, Chandra NC, Weaver WD. Factors influencing the time to thrombolysis in acute myocardial infarction. Arch Intern Med. 1997;157(22):2577-82. https://doi.org/10.1001/ archinte.1997.00440430059007

  15. Salerno SM, Alguire PC, Waxman HS. Competency in interpretation of 12-lead electrocardiograms: A summary and appraisal of published evidence. Ann Intern Med. 2003;138(9):751-60 [cited May 12, 2020]. Available from: https://www.acpjournals.org/doi/10.7326/0003-4819-138- 9-200305060-00013

  16. Jordan M, Caesar J. Improving door-to-needle times for patients presenting with ST-elevation myocardial infarction at a rural district general hospital. BMJ Qual Improv Rep. 2016;5(1). https://doi.org/10.1136/bmjquality. u209049.w6736

  17. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335- 51. https://doi.org/10.1002/(sici)1097-0258(20000215)19:3<335::aidsim336> 3.0.co;2-z

  18. National Cancer Institute. Joinpoint Regression Program [Software]. Version 4.5.0.1. Statistical Research and Applications. United States: National Cancer Institute [cited Jan 28, 2018]. Available from: https://surveillance. cancer.gov/joinpoint/

  19. Zhang Q, Zhao D, Xie W, Xie X, Guo M, Wang M, et al. Recent trends in hospitalization for acute myocardial infarction in Beijing: Increasing overall burden and a transition from ST-segment elevation to non-STsegment elevation myocardial infarction in a population-based study. Medicine. 2016;95(5):e2677. https://doi.org/10.1097/MD.0000000000002677

  20. Benjamin E, Blaha M, Chiuve E, Cushman E, Das S, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report from the American Heart Association. Circulation. 2017;135(10):e146–e603. https://doi. org/10.1161/CIR.0000000000000485

  21. Jennings SM, Bennett K, Lonergan M, Shelley E. Trends in hospitalization for acute myocardial infarction in Ireland, 1997-2008. Heart. 2012;98(17):1285-89. https://doi.org/10.1136/heartjnl-2012-301822

  22. Freisinger E, Fuerstenberg T, Malyar NM, Wellmann J, Keil U, Breithardt G, Reinecke H. German nationwide data on current trends and management of acute myocardial infarction: discrepancies between trials and real-life. Eur Heart J. 2014;35(15):979-88. https://doi.org/10.1093/ eurheartj/ehu043

  23. Reynolds K, Go AS, Leong TK, Boudreau DM, Cassidy-Bushrow AE, Fortmann SP, et al. Trends in Incidence of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN). Am J Med. 2017;130(3):317-27. https://doi.org/10.1016/j.amjmed.2016.09.014

  24. Chen H, Shi L, Xue M, Dong X, Wang N, Chen J, et al. Geographic Variations in In-Hospital Mortality and Use of Percutaneous Coronary Intervention Following Acute Myocardial Infarction in China: A Nationwide Cross-Sectional Analysis. J Am Heart Assoc. 2018;7(8):e008131 https://doi. org/10.1161/JAHA.117.008131

  25. Santos JD, Meira KC, Camacho AR, Salvador PT, Guimarães RM, Pierin ÂMG, et al. Mortality due to acute myocardial infarction in Brazil and its geographical regions: analyzing the effect of age-period-cohort. Cien Saude Colet. 2018;23(5):1621-34. https://doi.org/10.1590/1413- 81232018235.16092016

  26. Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2005;149(1):67-73. https://doi.org/10.1016/j. ahj.2004.06.003

  27. Yan RT, Yan AT, Tan M, Chow CM, Fitchett DH, Ervin FL, et al. Agerelated differences in the management and outcome of patients with acute coronary syndromes. Am Heart J. 2006;151(2):352-9. https://doi. org/10.1016/j.ahj.2005.03.039

  28. Prabhakaran D, Anand S, Gazian TA, Mbanya JC, Wu Y, Nugent R, eds. Cardiovascular, respiratory, and related disorders. Disease control priorities. 3rd. ed. Washington, DC: World Bank, 2017 [cited Jan 28, 2018]. Available from: http://dcp-3.org/cvd

  29. Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012;307(8):813-22. https:// doi.org/10.1001/jama.2012.199

  30. Shiraki T, Saito D. Sex difference of in-hospital mortality in patients with acute myocardial infarction. Acta Med Okayama. 2011;65:307-314. https://doi.org/10.18926/AMO/47013

  31. van der Meer MG, Nathoe HM, van der Graaf Y, Doevendans PA, Appelman Y. Worse outcome in women with STEMI: a systematic review of prognostic studies. Eur J Clin Invest. 2015;45(2):226-35. https://doi. org/10.1111/eci.12399

  32. Zhang Z, Fang J, Gillespie C, Wang G, Hong Y, Yoon PW. Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction. Am J Cardiol. 2012;109(8):1097-103. https://doi.org/10.1016/j. amjcard.2011.12.001

  33. Simon T, Mary-Krause M, Cambou JP, Hanania G, Guéret P, Lablanche JM, et al. Impact of age and gender on in-hospital and late mortality after acute myocardial infarction: increased early risk in younger women: results from the French nation-wide USIC registries. Eur Heart J. 2006;27(11):1282-8. https://doi.org/10.1093/eurheartj/ehi719

  34. Secretaría de Salud. Programa Nacional para la Reducción de la Mortalidad por Infarto Agudo al Miocardio IAM-MX (PREMIA). Ciudad de México: SS, 2018 [cited Jan 10, 2019]. Available from: http://www.calidad. salud.gob.mx/site/iam/

  35. Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med. 2003;348:933-40. https://doi. org/10.1056/NEJMra022700

  36. Bassand JP, Danchin N, Filippatos G, Gitt A, Hamm C, Silber S, et al. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J. 2005;26(24):2733-41. https://doi.org/10.1093/eurheartj/ehi673

  37. Rossello X, Huo Y, Pocock S, Van de Werf F, Chin CT, Danchin N, et al. Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality. Int J Cardiol. 2017;245:27- 34. https://doi.org/10.1016/j.ijcard.2017.07.039

  38. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003;56(2):124-30. https://doi. org/10.1016/s0895-4356(02)00591-7

  39. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(450). https://doi.org/10.1186/1471- 2458-11-450




2020     |     www.medigraphic.com